These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1854464)

  • 41. Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys.
    Gibson RE; Thorpe HH; Cartwright ME; Frank JD; Schorn TW; Bunting PB; Siegl PK
    Am J Physiol; 1991 Sep; 261(3 Pt 2):F512-8. PubMed ID: 1653532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.
    Cassis LA; Rippetoe PE; Soltis EE; Painter DJ; Fitz R; Gillespie MN
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1168-72. PubMed ID: 1527721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential regional haemodynamic effects of the non-peptide angiotensin II antagonist, DuP 753, in water-replete and water-deprived Brattleboro rats.
    Batin P; Gardiner SM; Compton AM; Bennett T
    Life Sci; 1991; 48(8):733-9. PubMed ID: 1994182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.
    Wong PC; Hart SD; Chiu AT; Herblin WF; Carini DJ; Smith RD; Wexler RR; Timmermans PB
    J Pharmacol Exp Ther; 1991 Nov; 259(2):861-70. PubMed ID: 1941632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dup 753 prevents the development of puromycin aminonucleoside-induced nephrosis.
    Yayama K; Kawao M; Tujii H; Itoh N; Okamoto H
    Eur J Pharmacol; 1993 May; 236(2):337-8. PubMed ID: 8319760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro pharmacology of DuP 753.
    Chiu AT; McCall DE; Price WA; Wong PC; Carini DJ; Duncia JV; Wexler RR; Yoo SE; Johnson AL; Timmermans PB
    Am J Hypertens; 1991 Apr; 4(4 Pt 2):282S-287S. PubMed ID: 1854453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
    Wong PC; Hart SD; Zaspel AM; Chiu AT; Ardecky RJ; Smith RD; Timmermans PB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):584-92. PubMed ID: 2243344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety, tolerability, pharmacokinetics, and pharmacodynamics of fimasartan following single and repeated oral administration in the fasted and fed states in healthy subjects.
    Chi YH; Lee H; Paik SH; Lee JH; Yoo BW; Kim JH; Tan HK; Kim SL
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):335-46. PubMed ID: 21910510
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacodynamic and pharmacokinetic properties of an angiotensin II receptor antagonist--characterization by use of Schild regression technique in man.
    Breithaupt-Grögler K; Malerczyk C; Belz GG; Butzer R; Herrmann V; Stass H; Wensing G
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):434-41. PubMed ID: 9352392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Angiotensin-II receptor blockers].
    Metelitsa VI
    Ter Arkh; 1996; 68(8):64-7. PubMed ID: 9019837
    [No Abstract]   [Full Text] [Related]  

  • 52. Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats.
    von Lutterotti N; Camargo MJ; Campbell WG; Mueller FB; Timmermans PB; Sealey JE; Laragh JH
    J Hypertens; 1992 Sep; 10(9):949-57. PubMed ID: 1328376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrating drug pharmacokinetics for phenotyping individual renin response to angiotensin II blockade in humans.
    Azizi M; Bissery A; Lamarre-Cliche M; Ménard J
    Hypertension; 2004 Apr; 43(4):785-90. PubMed ID: 15023936
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemodynamic effects of direct angiotensin II blockade compared to converting enzyme inhibition in rat model of heart failure.
    Raya TE; Fonken SJ; Lee RW; Daugherty S; Goldman S; Wong PC; Timmermans PB; Morkin E
    Am J Hypertens; 1991 Apr; 4(4 Pt 2):334S-340S. PubMed ID: 1854461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pharmacokinetics and metabolism of DuP 532, a non-peptide angiotensin II receptor antagonist, in rats and dogs.
    Wong YN; Holm KA; Burcham DL; Huang SM; Quon CY
    Biopharm Drug Dispos; 1994 Jan; 15(1):53-63. PubMed ID: 8161716
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Losartan/Hydrochlorothiazide: a review of its use in the treatment of hypertension and for stroke risk reduction in patients with hypertension and left ventricular hypertrophy.
    Keating GM
    Drugs; 2009 Jun; 69(9):1239-65. PubMed ID: 19537840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical pharmacokinetics of losartan.
    Sica DA; Gehr TW; Ghosh S
    Clin Pharmacokinet; 2005; 44(8):797-814. PubMed ID: 16029066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Population pharmacokinetic-pharmacodynamic modelling of angiotensin receptor blockade in healthy volunteers.
    Csajka C; Buclin T; Fattinger K; Brunner HR; Biollaz J
    Clin Pharmacokinet; 2002; 41(2):137-52. PubMed ID: 11888333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Losartan: a review of its use, with special focus on elderly patients.
    Simpson KL; McClellan KJ
    Drugs Aging; 2000 Mar; 16(3):227-50. PubMed ID: 10803861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.